Molecular Biology in Pediatric High-Grade Glioma: Impact on Prognosis and Treatment

Antonio Ruggiero, Maurizio Martini, Palma Maurizi, Daniela Rizzo, Valentina Rizzo, Riccardo Riccardi

Risultato della ricerca: Contributo in rivistaArticolo in rivista

35 Citazioni (Scopus)

Abstract

High-grade gliomas are the main cause of death in children with brain tumours. Despite recent advances in cancer therapy, their prognosis remains poor and the treatment is still challenging. To date, surgery followed by radiotherapy and temozolomide is the standard therapy. However, increasing knowledge of glioma biology is starting to impact drug development towards targeted therapies. The identification of agents directed against molecular targets aims at going beyond the traditional therapeutic approach in order to develop a personalized therapy and improve the outcome of pediatric high-grade gliomas. In this paper, we critically review the literature regarding the genetic abnormalities implicated in the pathogenesis of pediatric malignant gliomas and the current development of molecularly targeted therapies. In particular, we analyse the impact of molecular biology on the prognosis and treatment of pediatric high-grade glioma, comparing it to that of adult gliomas.
Lingua originaleEnglish
pagine (da-a)1-10
Numero di pagine10
RivistaBioMed Research International
Volume2015
DOI
Stato di pubblicazionePubblicato - 2015

Keywords

  • Adolescent
  • Adult
  • Biochemistry, Genetics and Molecular Biology (all)
  • Biomarkers, Tumor
  • Brain Neoplasms
  • Child
  • Child, Preschool
  • Female
  • Glioma
  • Humans
  • Immunology and Microbiology (all)
  • Infant
  • Male
  • Neoplasm Proteins

Fingerprint Entra nei temi di ricerca di 'Molecular Biology in Pediatric High-Grade Glioma: Impact on Prognosis and Treatment'. Insieme formano una fingerprint unica.

Cita questo